Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity EMVISION MEDICAL DEVICES LTD ABN/ARBN Financial year ended: 38 620 388 230 30 June...
Appendix 4G & Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
In the deck
Earlier from EMvision Medical Devices
- Change of Registered Office Address
- Aeromedical Study De-Risks Rural & Remote Stroke Use Cases
- EMVision to Receive $1.17M IGP Grant Instalment
- emu Pivotal Trial Expansion Adds Acute Ischaemia Detection
- $3.8m R&D Rebate Received & Overseas Finding Approved
Later from EMvision Medical Devices
- FY26 Results Presentation
- Appendix 4E & Annual Report to 30 June 2026
- emu Pivotal Trial Recruitment Surpasses 200 Patients
- emu Regional Benefits Study Advancing
- Notification regarding unquoted securities - EMV
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices